Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Change in Inventory: 2021-2024

Historic Change in Inventory for Apellis Pharmaceuticals (APLS) over the last 4 years, with Dec 2024 value amounting to $10.8 million.

  • Apellis Pharmaceuticals' Change in Inventory rose 37.59% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year decrease of 104.97%. This contributed to the annual value of $10.8 million for FY2024, which is 82.27% down from last year.
  • Latest data reveals that Apellis Pharmaceuticals reported Change in Inventory of $10.8 million as of FY2024, which was down 82.27% from $60.6 million recorded in FY2023.
  • Apellis Pharmaceuticals' 5-year Change in Inventory high stood at $69.4 million for FY2022, and its period low was $10.8 million during FY2024.
  • For the 3-year period, Apellis Pharmaceuticals' Change in Inventory averaged around $46.9 million, with its median value being $60.6 million (2023).
  • In the last 5 years, Apellis Pharmaceuticals' Change in Inventory skyrocketed by 325.30% in 2022 and then crashed by 82.27% in 2024.
  • Apellis Pharmaceuticals' Change in Inventory (Yearly) stood at $16.3 million in 2021, then soared by 325.30% to $69.4 million in 2022, then declined by 12.61% to $60.6 million in 2023, then crashed by 82.27% to $10.8 million in 2024.